
Election Science Stakes: Medicine and Public Health
Scientific American’s senior medicine editor Josh Fischman talks about issues in medicine and public health that will be affected by this election.

Election Science Stakes: Medicine and Public Health
Scientific American’s senior medicine editor Josh Fischman talks about issues in medicine and public health that will be affected by this election.

A Flu Shot Might Reduce Coronavirus Infections, Early Research Suggests
Hospital workers who got vaccinated were significantly less likely to develop COVID than those who did not

Sign up now to get 60 days of digital access

Billions of Dollars for Stem Cell Research Institute On California’s November Ballot
Voters must decide whether to keep financing the second largest funder of stem cell science in the world

COVID’s Other Toll: Unnecessary Tests and Huge Hospital Bills
They highlight one of the biggest problems in American health care

Human Challenge Trials Will Deliberately Infect Dozens in the U.K.
Proponents of the trials say they can be run safely and help to identify effective vaccines, but others have questioned their value

Don’t Expect a COVID Vaccine before the Election
A vaccine made by Pfizer could seek emergency approval by the third week of November, but it likely won’t be available to the public until mid- to late 2021

How to Take Racial Bias Out of Kidney Tests
A medical student describes winning her fight to change an equation that prevented Black people from getting crucial treatment

Why So Many Americans Are Skeptical of a Coronavirus Vaccine
It’s not just “antiscience thinking”

Lab-Made ‘Miniproteins’ Could Block the Coronavirus from Infecting Cells
Synthetic peptides that mimic human antibodies for COVID-19 could be cheaper and easier to produce

Neandertal DNA May Be COVID Risk
A stretch of Neandertal DNA has been associated with some cases of severe COVID-19, but it’s unclear how much of a risk it poses. Christopher Intagliata reports.

What China’s Speedy COVID Vaccine Deployment Means for the Pandemic
China has promised vaccines to many countries, but whether it can meet its commitments is unclear

Nobelist Talks CRISPR Uses
New Nobel laureate in chemistry Jennifer Doudna talks about various applications of the gene-editing tool CRISPR.